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Abstract 
The functional behavior of mitochondtia in skeletal muscle of patients with chronic progressive external ophthalmoplegia was studied 
by laser-excited fluorescence measurements of NAD(P)H and flavoproteins in saponin-skinned fibers. Variations in the mitochondrial 
content and the presence of partially respiratory chain-inhibited mitochondria can be detected using this novel method. 
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1. Introduction 
Recently an increasing number of diseases has been 
identified which are directly related to mitochondrial dys- 
function [l-3]. Within this group, chronic progressive 
external ophthalmoplegia (CPEO) is very common and is 
caused by deletions of the mitochondtial genome in most 
of the reported cases [4], by np 3243 MELAS mutation in 
the tRNAL”” [5] or the rare np 5692 mutation in the 
tRNA*“” [6]. The functional implications of these defects, 
however, are still a matter of speculation. To elucidate the 
mitochondrial function in chronic progressive ophthalmo- 
plegia, we report the use of saponin-skinned muscle fibers. 
This method of plasma membrane removal results in an 
unobstructed access to the mitochondria for substrates or 
ADP and allows the determination of the maximal oxida- 
tion capacities using low amounts of biological material 
[7]. Moreover, the mitochondriai function can be eluci- 
dated in these fibers using laser-excited fluorescence mea- 
surements of NAD(P)H and fluorescent flavoproteins [8]. 
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We observed that the presence of either partially respira- 
tory chain-inhibited mitochondria or a decreased number 
of almost functionally intact mitochondria in muscle were 
consistent with the clinical symptoms of CPEO. 
2. Patients and methods 
2. I. Patients 
S.B. is a 55year-old woman with mild myopathy and 
severe ptosis. M.T. is a 34-year-old woman with ptosis and 
myopathy. L.H. is a 63-year-old woman with exercise 
intolerance and severe ptosis. All three patients fulfil the 
clinical criteria of chronic progressive external ophthalmo- 
plegia. Elevated blood lactate levels (above 4 mM) - 
indicative for a diminished lactate utilization - were de- 
tected in all cases during the recovery phase after defined 
bicycle ergometry (75 W). In the muscle biopsy of S.B. 
and M.T., fibers with a very strong and spot-like stain for 
succinate dehydrogenase were found in combination with 
glycogen and lipid accumulation. In both cases deletions of 
the mitochondrial DNA in skeletal muscle were detected. 
S.B. harbored in 67% of mtDNA in muscle a 4.7 kb 
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deletion (including the positions np 6188 and np 10877); 
M.T. harbored in 53% of muscle mtDNA a 2.3 kb deletion 
(located between the Hind111 site at np 11680 and the 
XhoI site at np 14956). In the muscle biopsy of L.H., 
stains with the dye Sudan III revealed a strong increase of 
lipid droplets in the cytoplasm. The presence of deletions 
in this biopsy was ruled out by Southern blots of PvuII 
and BumHI digested mtDNA. 
to the perifusion chamber at the emission wavelength 450 
nm (NAD(P)H fluorescence) or 520 nm (flavoprotein fluo- 
rescence). 
3. Results and discussion 
2.2. Methods 
Bundles of fibers between 10 and 15 mg wet weight of 
M. vastus lateralis were obtained from the biopsy samples 
of myopathy patients and orthopedic patients (controls, age 
between 50 and 70 years) and treated with saponin as 
described in Ref. [7]. The respiration measurements were 
performed at 25°C using a high resolution Oroboros-oxy- 
graph (Anton Paar, Graz) [9] in a medium consisting of 
110 mM mannitol, 60 mM KCl, 10 mM KH2P0,, 5 mM 
MgCl,, 0.5 mM Na,EDTA and 60 mM Tris-HCl (pH = 
7.4). The measurements of enzyme activities in the muscle 
homogenate were performed at 30°C using a Cary 1 
spectrophotometer with standard methods in the medium 
for oxygraphic measurements [lo]. For the measurements 
of fluorescence of NAD(P)H and of fluorescent flavo- 
proteins, the experimental setup described in Ref. [8] was 
used. Between 2 and 5 mg wet weight skinned fibers were 
immobilized (by the attachment to glass wool) in a light- 
screened quartz tube and perifused at 1 ml/min with the 
medium used for the oxygraphic measurements. The 
NAD(P)H fluorescence was excited at 325 nm using the 8 
mW beam of an Omnichrom OMI-2056 HeCd dual-wave- 
length laser. The flavoprotein fluorescence was excited at 
454 nm using a 75 mW Omnichrom OMI-523 AP argon-ion 
laser. The excitation light was guided to the immobilized 
sample using a quartz fiber. The fluorescence light was 
monitored by a Shimadzu RF 5001 spectrofluorimeter 
connected at 90” (with respect to the excitation beam) with 
a quartz light guide (6 mm inner diameter, Schott, Mainz) 
In Table 1 the results of enzymatic and oxygraphic 
evaluation of mitochondrial function in the biopsy samples 
of the three patients with CPEO are summarized. In the 
biopsy samples of patients S.B. and L.H., the activities of 
the mitochondrial enzymes NADH:cytochrome-c reductase 
and cytochrome-c oxidase were markedly reduced, while 
in the biopsy of M.T. deviations from control values are 
visible only if the increase in citrate synthase activity is 
taken into consideration. From respiration measurements 
of saponin-skinned muscle fibers, it can be seen that the 
mitochondrial defects are visible as diminished maximal 
rates of mitochondrial oxygen consumption. 
Next, we analyzed the mitochondrial function in 
saponin-skinned fibers using measurements of fluores- 
cence of NAD(P)H and fluorescent flavoproteins [8]. This 
method allows the determination of redox state changes of 
mitochondrial pyridine nucleotides on substrate, ADP and 
inhibitor additions. In Fig. 1 laser-excited NAD(P)H auto- 
fluorescence changes of saponin-skinned fibers are shown 
from human vastus lateralis muscle of an orthopedic pa- 
tient (left> and of the patients M.T. and L.H. The addition 
of the mitochondrial substrates pyruvate + malate led in 
the experiments to an increase in NAD(P)H fluorescence. 
Addition of ADP, which causes under these circumstances 
a stimulation of mitochondrial respiration rate [8], resulted 
in a reoxidation of mitochondrial NADH visible as de- 
crease of fluorescence. Glutamate, which improves the 
supply of reducing equivalents, caused thereafter a reduc- 
tion of NAD+. The total content of fluorochromes can be 
estimated by the addition of cyanide, causing the maximal 
reduction of the mitochondrial NAD-pool [8]. 
The traces presented on Fig. 1 show that a considerably 
Table 1 
Enzyme activities in the muscle homogenates and maximal rates of respiration of saponin-skinned muscle fibers 
Controls M.T. L.H. S.B. 
Citrate synthase 5.1 + 2.0 12.5 + 0.2 1.4 + 0.1 11.4*0.1 
(n = 25) 
NADH:cytochrome-c reductase 3.0 + 0.8 3.6 * 0.2 0.7 f 0.2 1.5 f 0.2 
(n = 25) 
Cytochrome-c oxidase 3.8 + 1.2 4.8 + 0.2 0.8 + 0.2 0.34 + 0.01 
(n = 25) 
Glutamate + malate supported respiration 8.0 + 2.0 6.2 + 0.8 3.0 + 1.0 6.6 0.14 * 
(n = 48) 
Succinate supported respiration 9.2 f 2.5 8.3 f 2.1 6.2 5.3 
(n = 48) 
The enzyme activity values are expressed in U/g wet weight determined at 30°C (means + S.D. of a triplicate determination). n, number of orthopedic 
controls. The maximal rates of respiration (in nmol O,/min/mg dry weight) were determined at 25°C using the substrates 10 mM succinate + 10 FM 
rotenone or 10 mM glutamate + 5 mM malate in the presence of I mM ADP. 
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Fig. 1. Fluorescence changes of NAD(P)H in saponin-skinned human 
muscle fibers. Between 4 mg and 2 mg wet weight skinned fibers from 
M. vastus lateralis were attached to glass wool and perifused as described 
in the text. The sample was excited at 325 nm, the fluorescence was 
registrated at 450 nm. Left trace, control; right traces, patients M.T. and 
L.H. Additions to the perifusion medium: pyruvate (PYR), 5 mM; malate 
(MAL), 5 mM; ADP, I mM; glutamate (GLU), IO mM; KCN, 4 mM. 
lowered reoxidation of mitochondrial NADH on ADP 
addition took place in the case of the patient M.T. This 
result can most likely be due to partial inhibition of the 
respiratory chain, which caused a decreased efflux of 
reducing equivalents from the mitochondrial NAD-pool 
under the conditions of ADP-stimulation. Moreover, the 
total fluorescence change was elevated for the patient M.T. 
and reduced for the patient L.H. 
Additionally, we performed measurements of the flavo- 
protein fluorescence shown in Fig. 2. In human skeletal 
muscle fibers this fluorescence signal, measured at 454 nm 
excitation and 520 nm emission, originates almost exclu- 
sively from the oxidized form of the FAD-containing 
cw-lipoamide dehydrogenase being in direct redox contact 
with the mitochondrial NAD-pool [8,11]. In comparison to 
control fibers a much lower reoxidation of flavoproteins on 
ADP addition (visible in this case as fluorescence increase) 
was detected for M.T. and S.B. This finding is in line with 
the presence of partially respiratory chain-inhibited mito- 
chondria in the muscle biopsy of the patients M.T. and 
S.B. In Table 2 the determinations of redox states of 
NAD(P)H and fluorescent flavoproteins with different 
M.T. S.B. 4 min 
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Fig 2. Fluorescence changes of fluorescent flavoproteins in saponin- 
skinned human muscle fibers. About 3 mg wet weight skinned fibers 
from M. vastus lateralis were attached to glass wool and perifused as 
described in the text. The sample was excited at 454 nm, the fluorescence 
was registrated at 520 nm. Left trace, control; right traces, patients M.T. 
and S.B. Additions to the perifusion medium: octanoylcarnitine (OC), I 
mM; malate (MALI, 5 mM; ADP, 1 mM; glutamate (GLU). 10 mM; 
KCN, 4 mM; dithionite (DIT), I5 mM. 
mitochondrial substrates are summarized for all three pa- 
tients and controls. For S.B. and M.T. elevated redox 
states were detected with all substrates investigated. On the 
contrary, the patient L.H. exhibited almost normal redox 
states. In addition to these measurements, we compared the 
absolute intensities of laser-excited fluorescences [8]. For 
the patient M.T. we detected elevated absolute autofluo- 
rescence intensities, while the fluorescence intensities in 
the muscle fibers of L.H. and to some extent also of S.B. 
were reduced. 
Chronic progressive external ophthalmoplegia is re- 
ported to be caused either by deletions of mitochondrial 
DNA [4], by np 3243 MELAS mutation in tRNAL’” [5], or 
by the rare np 5692 mutation in tRNAA”” [6]. As a 
consequence of point mutations, an impaired synthesis of 
mitochondrially encoded proteins, most probably due to 
the competition of mutated and nonmutated tRNA’s, is 
expected [6]. This concept rather easily explains the pres- 
ence of mitochondria with a partially inhibited respiratory 
chain. More problematic is the explanation of the presence 
of partially respiratory chain-inhibited mitochondria in 
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The redox states are given in % of the fluorescence change between the fully oxidized state (in the absence of substrates) and the completely reduced state 
(in the presence of substrates and 4 mM cyanide). They were determined in the presence of I mM ADP and different combinations of substrates: IO mM 
glutamate + 5 mM malate (glu + ma]), 5 mM pyruvate + 5 mM malate (pyr + maI) or 1 mM octanoylcamitine + 5 mM malate (oc + ma]). The content of 
NAD(P)H and fluorescent flavoproteins (in arbitrary units) was determined from the absolute respiratory chain-dependent autofluorescence changes 
calibrated with NADH or riboflavin as fluorescence standards, respectively (cf. Refs. [8, I I]). n, number of orthopedic controls. 
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cases with rather big deletions of the mtDNA [ 121. As a 
matter of fact, mitochondria containing exclusively 
genomes harboring a deletion, affecting as in our case the 
complete COI, CO11 and CO111 genes (S.B.) or the ND5 
and ND6 genes (M.T.), would be totally inactive from a 
functional point of view. Applying laser-excited fluores- 
cence measurements, we should observe under these cir- 
cumstances a higher background NAD(P)H fluorescence 
and lower background flavoprotein fluorescence (the mito- 
chondrial NAD-system should remain reduced because of 
an almost complete block of the respiratory chain). We 
observed fluorescence changes which can be explained 
only by a larger (M.T.) or slightly diminished (S.B.1 
population of at least partially ‘intact’ mitochondria. This 
seems to be an indication that all these mitochondria 
detectable by fluorimetry contain at least one copy of the 
wild-type genome. Therefore, a competition of wt- and 
A-mRNA’s for protein biosynthesis seems to be an appro- 
priate explanation for the functional defect in the described 
cases, similar to the effects proposed to occur in point 
mutations of tRNA genes [6]. This explanation is in line 
with reports about cybrids of mitochondria harboring a 
partially deleted genome and of mtDNA-less HeLa cells, 
suggesting that mitochondria within a cell can be consid- 
ered as a single dynamic unit with a rather homogeneous 
distribution of wt- and A-mtDNA molecules [ 13,141. 
In contrast to the findings for the patients M.T. and 
S.B., we observed a decreased amount of the mitochon- 
drial marker enzyme citrate synthase along with lowered 
rates of skinned fiber respiration in the muscle biopsy of 
L.H. In agreement with these data the absolute autofluo- 
rescence intensities in the muscle fibers of L.H. were also 
diminished. A possible contamination of the biopsy speci- 
men with connective tissue was ruled out by histology. 
Moreover, cytosolic enzymes involved in glycolysis, such 
as lactate dehydrogenase and pyruvate kinase were in the 
usual range. In this case of putative mitochondrial dysfunc- 
tion, no deletion of the mtDNA was observed. However, 
from the clinical point of view, this patient exhibits the 
classical features of CPEO. This strongly supports the 
suggestion that a diminished amount of functionally intact 
mitochondria, caused most probably by a defect in the 
mitochondrial biogenesis, can also lead to the symptoms of 
CPEO. 
Summarizing, measurements of fluorescence changes of 
mitochondrial NAD(P)H and fluorescent flavoproteins by 
laser-excited fluorimetry of skinned muscle fibers provide 
important information about the functional behavior and 
content of mitochondria in diseased muscle. 
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